Tharimmune Statistics

Total Valuation

Tharimmune has a market cap or net worth of $2.57 million. The enterprise value is -$1.02 million.

Market Cap	2.57M
Enterprise Value	-1.02M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Tharimmune has 2.11 million shares outstanding. The number of shares has increased by 1,388.64% in one year.

Current Share Class	2.11M
Shares Outstanding	2.11M
Shares Change (YoY)	+1,388.64%
Shares Change (QoQ)	+15.39%
Owned by Insiders (%)	1.48%
Owned by Institutions (%)	7.40%
Float	2.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.82
P/TBV Ratio	1.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.54

Current Ratio	1.54
Quick Ratio	1.47
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-908.64

Financial Efficiency

Return on equity (ROE) is -233.69% and return on invested capital (ROIC) is -148.89%.

Return on Equity (ROE)	-233.69%
Return on Assets (ROA)	-105.96%
Return on Invested Capital (ROIC)	-148.89%
Return on Capital Employed (ROCE)	-950.86%
Revenue Per Employee	n/a
Profits Per Employee	-$4.07M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.04% in the last 52 weeks. The beta is 1.20, so Tharimmune's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	-78.04%
50-Day Moving Average	1.44
200-Day Moving Average	2.27
Relative Strength Index (RSI)	44.27
Average Volume (20 Days)	98,761

Short Selling Information

The latest short interest is 64,361, so 3.05% of the outstanding shares have been sold short.

Short Interest	64,361
Short Previous Month	30,196
Short % of Shares Out	3.05%
Short % of Float	3.10%
Short Ratio (days to cover)	0.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.43M
Pretax Income	-8.88M
Net Income	-12.20M
EBITDA	n/a
EBIT	-12.43M
Earnings Per Share (EPS)	-$9.41

Full Income Statement

Balance Sheet

The company has $3.56 million in cash and n/a in debt, giving a net cash position of $3.56 million or $1.69 per share.

Cash & Cash Equivalents	3.56M
Total Debt	n/a
Net Cash	3.56M
Net Cash Per Share	$1.69
Equity (Book Value)	1.31M
Book Value Per Share	0.66
Working Capital	1.31M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.90M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tharimmune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,388.64%
Shareholder Yield	-1,388.64%
Earnings Yield	-479.94%
FCF Yield	n/a

Analyst Forecast

The average price target for Tharimmune is $17.00, which is 1,293.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	1,293.44%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1